| Autor: |
Roboz GJ; Weill Cornell Medical College, New York, NY; New York Presbyterian Hospital, New York. gar2001@med.cornell.edu., Döhner H; Ulm University Hospital, Ulm., Pocock C; Kent and Canterbury Hospital, Canterbury., Dombret H; Hôpital Saint-Louis, Assistance Publique - Hôpitaux de Paris (AP-HP) and Institut de Recherche Saint-Louis, Université de Paris, Paris., Ravandi F; The University of Texas MD Anderson Cancer Center, Houston., Jang JH; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul., Selleslag D; AZ Sint-Jan Brugge-Oostende AV, Bruges., Mayer J; University Hospital Brno, Brno, Czech Republic., Martens UM; SLK-Kliniken GmbH, MOLIT Institute for Personalized Medicine, Heilbronn., Liesveld J; Wilmot Cancer Institute, University of Rochester, New York., Bernal T; Hospital Universitario Central de Asturias, Oviedo., Wang MC; Chang Gung Medical Foundation, Kaohsiung., Yu P; Evidera, Waltham., Shi L; Evidera, Waltham., Guo S; Evidera, Waltham., La Torre I; Celgene, a Bristol-Myers Squibb Company, Boudry., Skikne B; Bristol Myers Squibb, Princeton, NJ; University of Kansas Medical Center, Kansas City., Dong Q; Bristol Myers Squibb, Princeton., Braverman J; Bristol Myers Squibb, Princeton., Nehme SA; Celgene, a Bristol-Myers Squibb Company, Boudry., Beach CL; Bristol Myers Squibb, Princeton., Wei AH; The Alfred Hospital and Monash University, Melbourne. |
